{
    "clinical_study": {
        "@rank": "23382", 
        "arm_group": {
            "arm_group_label": "Mesenchymal stem cell", 
            "arm_group_type": "Other", 
            "description": "transfer of Mesenchymal Stem Cell ( MSCs )"
        }, 
        "brief_summary": {
            "textblock": "Retinitis pigmentosa is an eye disease in which there is damage to the retina. The retina is\n      the layer of tissue at the back of the inner eye that converts light images to nerve signals\n      and sends them to the brain.Stem cell therapy is used as therapy for this condition ."
        }, 
        "brief_title": "Clinical Study to Evaluate Safety and Efficacy of Stem Cell Therapy in Retinitis Pigmentosa", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Retinitis Pigmentosa", 
        "condition_browse": {
            "mesh_term": [
                "Retinitis", 
                "Retinitis Pigmentosa"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will involve about 8 visits over 1\u00bd years .Each participant will be enrolled in\n      study as per inclusion and exclusion criteria .Informed consent will be taken from subject\n      before including in study.  Subject will be underwent for specific tests of the\n      participant's vision and health. These visits may include visual exams, blood draw for\n      laboratory testing, brief medical history and exam, and occasionally a questionnaire\n      (survey), in addition to the visit for the surgical procedures. The primary outcome for this\n      study will be a visual acuity score after one year of stem cell therapy .\n\n      Follow-up visits  will be required regularly to determine  the effectiveness of stem cell\n      therapy in  RP."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18-65\n\n          -  Diagnosis of retinitis pigmentosa\n\n          -  willingness to undergo Bone marrow and umbilical cord derived Mesenchymal stem cell\n             transplantation.\n\n          -  To give an informed consent as well as sign the required Informed Consent Form (ICF)\n             for the study.\n\n          -  willingness to regularly visit the hospital / clinic for follow up during the follow\n             up period / on prior agreed time points as per the protocol.\n\n        Exclusion Criteria:\n\n          -  Positive test results for HIV and AIDS complex ,HCV (hepatitis C virus ), HbsAg and\n             Syphilis\n\n          -  Women who are pregnant or lactating\n\n          -  Complications of diabetic retinopathy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914913", 
            "org_study_id": "CSCC/BMRP/2013//01"
        }, 
        "intervention": {
            "arm_group_label": "Mesenchymal stem cell", 
            "description": "Intervention therapy , Total 6 doses ,in 30 days ,in 7days interval ,transfer of Bone marrow derived Mesenchymal Stem Cell ( MSCs ).", 
            "intervention_name": "Transfer of Mesenchymal Stem Cell ( MSCs )", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "retinitis pigmentosa", 
            "Bone marrow", 
            "Mesenchymal stem cell"
        ], 
        "lastchanged_date": "October 8, 2013", 
        "location": {
            "contact": {
                "email": "sac2751982@gmail.com", 
                "last_name": "Sachin P Jamadar, D ORTHO", 
                "phone": "+918888788880"
            }, 
            "facility": {
                "address": {
                    "city": "Pune,", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "411030"
                }, 
                "name": "Chaitanya Hospital"
            }, 
            "investigator": {
                "last_name": "Anant E Bagul, MS,Ortho", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open Labeled Clinical Study to Evaluate the Safety and Efficacy Mesenchymal Stem Cell in Retinitis Pigmentosa.", 
        "overall_contact": {
            "email": "sac2751982@gmail.com", 
            "last_name": "Sachin P Jamadar, D.Ortho", 
            "phone": "918888788880"
        }, 
        "overall_contact_backup": {
            "email": "drsmitabhoyar@rediff.com", 
            "last_name": "Smita S Bhoyar, B.A.M.S.PGCR", 
            "phone": "9372620569"
        }, 
        "overall_official": {
            "affiliation": "Chaitanya Hospital", 
            "last_name": "ANANT E BAGUL, MS ORTHO", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Electronic Visual Acuity (EVA) technology", 
            "measure": "visual acuity", 
            "safety_issue": "No", 
            "time_frame": "1 YEAR"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914913"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chaitanya Hospital, Pune", 
            "investigator_full_name": "Dr. Sachin Jamadar", 
            "investigator_title": "Co -investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Chaitanya Hospital, Pune", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chaitanya Hospital, Pune", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}